• Welcome Guest user
  • Log in | Register
 
Athens log in
Username Password  
Forgot your password?
Subscribe now to view full content , or if you already have an account,
please Login to access this feature
Subscribe now to view full content, or if you already have an account,
please Login to access this feature
Subscribe now to access this feature, or if you already have an account,
please Login.
 
 
  • Advanced search
Cambridge University Press logo
Stahl's Essential Psychopharmacology Online
In Collaboration With NEI
Stahl's Essential Psychopharmacology

Navigation

  • Home
  • Essential Psychopharmacology
  • Prescriber's Guide
  • Stahl's Illustrated
  • DrugInteraction
  • Teachers Set
 
  • My Bookmarks
  • Disclaimer
  • TOC
  • Chapter 5
  • My Images
  • Preface to the Third Edition
  • CME Information
  • Suggested Readings
  • Index
Please subscribe for full access.

Chapter 5

Ion Channels and Enzymes as Targets of Psychopharmacological Drug Action

  • Ligand-gated ion channels as targets of psychopharmacological drug action
  • Ligand-gated ion channels, ionotrophic receptors and ion channel–linked receptors: different terms for the same receptor/ion channel complex
  • Ligand-gated ion channels: structure and function
  • Pentameric subtypes
  • Tetrameric subtypes
  • The agonist spectrum
  • Different states of ligand-gated ion channels
  • Allosteric modulation: PAMs and NAMs
  • GABA, glutamate, and regulation of ligand-gated ion channels
  • Voltage-sensitive ion channels as targets of psychopharmacological drug action
  • Structure and function
  • Voltage-sensitive sodium channels (VSSCs)
  • Voltage-sensitive calcium channels (VSCCs)
  • Ion channels and neurotransmission
  • Enzymes as sites of psychopharmacological drug action
  • Other novel or potential targets of psychopharmacological drug action
  • Summary

Ion Channels and Enzymes as Targets of Psychopharmacological Drug Action

Many important psychopharmacological drugs target ion channels or enzymes. The roles of ion channels and enzymes as important regulators of synaptic neurotransmission have been covered in previous chapters (Chapters 1, 2, and 3). Here we discuss how the targeting of these molecular sites causes alterations in synaptic neurotransmission that are linked, in turn, to the therapeutic actions of various psychotropic drugs. Specifically, we will cover ligand-gated ion channels and voltage-sensitive ion channels as well as enzymes as targets of psychopharmacological drug action. We will also briefly mention a few additional novel or potential targets of drug action.

 
 

Current Prices for Individual Subscribers (prices are subject to change)

  Pay-per-view Subscription (48 hours) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 3rd Edition

ISBN: 9780511447990


$ 40
  Annual Subscription (Single User) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 3rd Edition

ISBN: 9780511447983


$ 195
  Print + Online Access (One Year, Single User) Unit price

Purchase

Stahl's Essential Psychopharmacology Online

Digital Edition: Print and Online

Once you are sent the Digital Edition, just enter the code from the inside back cover to activate your one-year access to www.stahlonline.org.

ISBN: 9780521746090


$225
For pricing and information for Academic and Medical Libraries, Corporate, Nonprofit or Government Institutions and/or special sales or website sponsorship,

for the Americas please contact:
Cambridge Library Sales,
stahlonline@cambridge.org,
800-221-4512, x6535.

For the rest of the world, please contact:
academicsales@cambridge.org
or call +44 (0) 1223 325741.

Australia and New Zealand
Phone: +61 (3) 8671 1400,
Fax: +61 3 9676 9966,
Email: enquiries@cambridge.edu.au.

 

back to top

Please wait, page is loading...
 

Footer links

  • About Cambridge University Press
  • About NEI
  • About Dr. Stahl
  • About the Illustrator
  • © Cambridge University Press 2008.
  • Copyright statement
  • Privacy Policy
  • Accessibility
  • Terms of use
  • FAQ
  • Help
  • View Access Details
  • Contact us